[go: up one dir, main page]

AU2003232844A1 - Morpholin-acetamide derivatives for the treatment of inflammatory diseases - Google Patents

Morpholin-acetamide derivatives for the treatment of inflammatory diseases

Info

Publication number
AU2003232844A1
AU2003232844A1 AU2003232844A AU2003232844A AU2003232844A1 AU 2003232844 A1 AU2003232844 A1 AU 2003232844A1 AU 2003232844 A AU2003232844 A AU 2003232844A AU 2003232844 A AU2003232844 A AU 2003232844A AU 2003232844 A1 AU2003232844 A1 AU 2003232844A1
Authority
AU
Australia
Prior art keywords
morpholin
treatment
inflammatory diseases
acetamide derivatives
acetamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003232844A
Inventor
Caroline Mary Cook
Colin David Eldred
Lee Andrew Harrison
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2003232844A1 publication Critical patent/AU2003232844A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003232844A 2002-05-29 2003-05-27 Morpholin-acetamide derivatives for the treatment of inflammatory diseases Abandoned AU2003232844A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0212355A GB0212355D0 (en) 2002-05-29 2002-05-29 Novel compounds
GB0212355.2 2002-05-29
PCT/EP2003/005717 WO2003099287A1 (en) 2002-05-29 2003-05-27 Morpholin-acetamide derivatives for the treatment of inflammatory diseases

Publications (1)

Publication Number Publication Date
AU2003232844A1 true AU2003232844A1 (en) 2003-12-12

Family

ID=9937625

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003232844A Abandoned AU2003232844A1 (en) 2002-05-29 2003-05-27 Morpholin-acetamide derivatives for the treatment of inflammatory diseases

Country Status (3)

Country Link
AU (1) AU2003232844A1 (en)
GB (1) GB0212355D0 (en)
WO (1) WO2003099287A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101011848B1 (en) 2004-09-08 2011-02-01 미쓰비시 타나베 파마 코퍼레이션 Morpholine compounds
JP5313881B2 (en) 2007-04-04 2013-10-09 興和株式会社 Tetrahydroisoquinoline compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3593037B2 (en) * 1998-11-20 2004-11-24 エフ.ホフマン−ラ ロシュ アーゲー Pyrrolidine derivative CCR-3 receptor antagonist
CA2423251A1 (en) * 2000-09-29 2002-04-04 Glaxo Group Limited Morpholin-acetamide derivatives for the treatment of inflammatory diseases

Also Published As

Publication number Publication date
GB0212355D0 (en) 2002-07-10
WO2003099287A1 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
GB0312832D0 (en) 2-amino-pyridine derivatives useful for the treatment of diseases
PL362711A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
AU2003279338A1 (en) Phenethanolamine derivatives for the treatment of respiratory diseases
AU2003285091A1 (en) Interferon antagonists useful for the treatment of interferon related diseases
AU2003228819A1 (en) Combinations for the treatment of inflammatory skin disorders
AU2003295890A1 (en) Anilinopyrazole derivatives useful for the treatment of diabetes
PT1487828E (en) Morpholinyl-urea derivatives for use of the treatment of inflamatory diseases
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
EP1611120A4 (en) Novel methods for the treatment of inflammatory diseases
AU2003265842A1 (en) Anabaseine derivatives useful in the treatment of neurodegenerative diseases
AU2003223538A1 (en) Methods for the treatment of cancer
AU2003220483A1 (en) Substituted pyrazolyl compounds for the treatment of inflammation
AU2003272962A1 (en) Remedies for allergic diseases
AU2003245880A1 (en) Process for the preparation of thioalkylamine derivatives
AU2003296242A1 (en) Thia-epothilone derivatives for the treatment of cancer
AU2003232844A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
AU2003240174A1 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
AU2003264822A1 (en) Epothilone derivatives for the treatment of multiple myeloma
AU2003252187A1 (en) Topical composition for the treatment of inflammatory conditions of the skin
AU2003208809A1 (en) Treatment of neuroblastoma
AU2003295504A1 (en) Development of therapeutics for the treatment of endotoxin-mediated diseases
HK40032312A (en) Administration of agents for the treatment of inflammation
AU2003244633A1 (en) Methods for the treatment of sinusitis
AU2002343085A1 (en) Tnf-alpha inhibitors for the treatment of hepatic diseases
HK1057753A (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase